These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 10660951)
1. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951 [TBL] [Abstract][Full Text] [Related]
2. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470 [TBL] [Abstract][Full Text] [Related]
3. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide. Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. Konaka A; Nishijima M; Tanaka A; Kunikata T; Kato S; Takeuchi K J Physiol Pharmacol; 1999 Mar; 50(1):25-38. PubMed ID: 10210152 [TBL] [Abstract][Full Text] [Related]
5. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1. Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858 [TBL] [Abstract][Full Text] [Related]
6. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. Satoh H; Amagase K; Takeuchi K J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201 [TBL] [Abstract][Full Text] [Related]
7. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats. Takeuchi K; Hatazawa R; Tanigami M; Tanaka A; Ohno R; Yokota A Life Sci; 2007 Jan; 80(4):329-36. PubMed ID: 17045617 [TBL] [Abstract][Full Text] [Related]
8. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Takeuchi K; Yokota A; Tanaka A; Takahira Y Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T Digestion; 2002; 66(1):30-41. PubMed ID: 12379813 [TBL] [Abstract][Full Text] [Related]
10. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Khattab MM; Gad MZ; Abdallah D Pharmacol Res; 2001 May; 43(5):463-7. PubMed ID: 11394938 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats. Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037 [TBL] [Abstract][Full Text] [Related]
12. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins. Heeba GH; Hassan MK; Amin RS Eur J Pharmacol; 2009 Apr; 607(1-3):188-93. PubMed ID: 19217901 [TBL] [Abstract][Full Text] [Related]
13. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism. Kato N; Mashita Y; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800 [TBL] [Abstract][Full Text] [Related]
14. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats. Tanaka A; Mizoguchi H; Kunikata T; Miyazawa T; Takeuchi K J Physiol Paris; 2001; 95(1-6):35-41. PubMed ID: 11595416 [TBL] [Abstract][Full Text] [Related]
15. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors. Ohno R; Yokota A; Tanaka A; Takeuchi K J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats. Nishio H; Hayashi Y; Terashima S; Takeuchi K Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018 [TBL] [Abstract][Full Text] [Related]
17. Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats. Kato S; Ohkawa F; Ito Y; Amagase K; Takeuchi K J Physiol Pharmacol; 2009 Dec; 60(4):147-55. PubMed ID: 20065509 [TBL] [Abstract][Full Text] [Related]
18. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats. Takeuchi K; Takehara K; Kato S J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993 [TBL] [Abstract][Full Text] [Related]
19. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K Digestion; 2000; 61(1):39-46. PubMed ID: 10671773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]